Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ravasio

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Neuromuscular Diseases|February 2, 2024
Expert Insights from a Delphi-driven Neurologists' Panel: Real-world Mexiletine use in Patients with Myotonic Disorders in ItalyDario Lidonnici, Pietro Brambilla, Roberto Ravasio, et al.
Oncogene|December 4, 2021
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AMLLuciano Nicosia, Francesca Ludovica Boffo, Elena Ceccacci, et al.
Plos One|August 10, 2023
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational ageIan P Keary, Roberto Ravasio, John R Fullarton, et al.
Clinical Drug Investigation|September 12, 2008
Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS settingFrancesco Di Costanzo, Roberto Ravasio, Alberto Sobrero, et al.
Journal of Clinical Medicine|August 14, 2020
MicroRNA-222 Regulates Melanoma PlasticityMaria Chiara Lionetti, Filippo Cola, Oleksandr Chepizhko, et al.
Science Advances|April 15, 2020
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiationRoberto Ravasio, Elena Ceccacci, Luciano Nicosia, et al.
Dermatology Practical & Conceptual|March 21, 2025
Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in ItalyFederico Pirro, Giacomo Caldarola, Nicoletta Bernardini, et al.
Nature Communications|January 27, 2024
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansionRani Pallavi, Elena Gatti, Tiphanie Durfort, et al.
Science Signaling|December 19, 2023
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronavirusesLuca Mazzarella, Fabio Santoro, Roberto Ravasio, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Neuromuscular Diseases|February 2, 2024
Expert Insights from a Delphi-driven Neurologists' Panel: Real-world Mexiletine use in Patients with Myotonic Disorders in ItalyDario Lidonnici, Pietro Brambilla, Roberto Ravasio, et al.
Oncogene|December 4, 2021
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AMLLuciano Nicosia, Francesca Ludovica Boffo, Elena Ceccacci, et al.
Plos One|August 10, 2023
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational ageIan P Keary, Roberto Ravasio, John R Fullarton, et al.
Clinical Drug Investigation|September 12, 2008
Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS settingFrancesco Di Costanzo, Roberto Ravasio, Alberto Sobrero, et al.
Journal of Clinical Medicine|August 14, 2020
MicroRNA-222 Regulates Melanoma PlasticityMaria Chiara Lionetti, Filippo Cola, Oleksandr Chepizhko, et al.
Science Advances|April 15, 2020
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiationRoberto Ravasio, Elena Ceccacci, Luciano Nicosia, et al.
Dermatology Practical & Conceptual|March 21, 2025
Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in ItalyFederico Pirro, Giacomo Caldarola, Nicoletta Bernardini, et al.
Nature Communications|January 27, 2024
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansionRani Pallavi, Elena Gatti, Tiphanie Durfort, et al.
Science Signaling|December 19, 2023
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronavirusesLuca Mazzarella, Fabio Santoro, Roberto Ravasio, et al.
Pageof 4